CATALIO CAPITAL MANAGEMENT
Catalio Capital Management is a Venture capital investments in breakthrough biomedical technology companies.
CATALIO CAPITAL MANAGEMENT
Industry:
Biotechnology Financial Services Venture Capital
Founded:
2016-01-01
Status:
Active
Contact:
(410) 989-6168
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag Google Maps Cloudflare JS
Similar Organizations
Amasia
Amasia is a venture capital investment firm that invests from Seed to Series B stages.
Felix Capital
Felix Capital is a venture fund that focuses on digital commerce, digital media, and information technology companies.
Longitude Capital
Longitude Capital is a venture capital firm that invests in biotechnology and medical technology companies.
Rivas Capital
Rivas Capital is a private investment firm focused on long-term principal investments in breakthrough technology businesses.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-15 | Fractyl Health | Catalio Capital Management investment in Series F - Fractyl Health | N/A |
| 2022-07-19 | Cartography Biosciences | Catalio Capital Management investment in Series A - Cartography Biosciences | 57 M USD |
| 2022-07-13 | Xilis | Catalio Capital Management investment in Series A - Xilis | 19 M USD |
| 2022-06-08 | Anagenex | Catalio Capital Management investment in Series A - Anagenex | 30 M USD |
| 2022-05-17 | Character Biosciences | Catalio Capital Management investment in Series A - Character Biosciences | 18 M USD |
| 2022-04-28 | Octant Bio | Catalio Capital Management investment in Series B - Octant Bio | 80 M USD |
| 2022-04-26 | Pheast Therapeutics | Catalio Capital Management investment in Series A - Pheast Therapeutics | 76 M USD |
| 2022-03-24 | Celsius Therapeutics | Catalio Capital Management investment in Series B - Celsius Therapeutics | 83 M USD |
| 2022-03-22 | Affini-T Therapeutics | Catalio Capital Management investment in Venture Round - Affini-T Therapeutics | 175 M USD |
| 2022-03-15 | PrognomiQ | Catalio Capital Management investment in Venture Round - PrognomiQ | 46 M USD |